Gene · 2173
Papers2,926
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,926
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Silencing of circular RNA PUM1 inhibits clear cell renal cell carcinoma progression through the miR-340-5p/FABP7 axis. | J Recept Signal Transduct Res | 2022 | 33472512 | PubTator, text mining | PubMed |
Electrospun conductive nanofiber yarns for accelerating mesenchymal stem cells differentiation and maturation into Schwann cell-like cells under a combination of electrical stimulation and chemical induction. | Acta Biomater | 2022 | 33271357 | PubTator, text mining | PubMed |
| HER2-positive breast cancer brain metastasis: A new and exciting landscape. | Cancer Rep (Hoboken) | 2022 | 32881421 | PubTator, text mining | PubMed |
| Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targets. | Explor Target Antitumor Ther | 2021 | 36046433 | PubTator, text mining | PubMed |
| Maternal Fatty Acid Metabolism in Pregnancy and Its Consequences in the Feto-Placental Development. | Front Physiol | 2021 | 35126178 | PubTator, text mining | PubMed |
| Metabolic Reprogramming Underlying Brain Metastasis of Breast Cancer. | Front Mol Biosci | 2021 | 35071325 | PubTator, text mining | PubMed |
| Electrical Stimulation and Conductive Polymers as a Powerful Toolbox for Tailoring Cell Behaviour in vitro. | Front Med Technol | 2021 | 35047926 | PubTator, text mining | PubMed |
| Cancer metabolism and intervention therapy. | Mol Biomed | 2021 | 35006438 | PubTator, text mining | PubMed |
| Differentially Expressed Genes in Clear Cell Renal Cell Carcinoma as a Potential Marker for Prognostic and Immune Signatures. | Front Oncol | 2021 | 34976818 | PubTator, text mining | PubMed |
| An Efficient Algorithm for the Detection of Outliers in Mislabeled Omics Data. | Comput Math Methods Med | 2021 | 34976114 | PubTator, text mining | PubMed |
| Identification of TGFβ signaling as a regulator of interneuron neurogenesis in a human pluripotent stem cell model. | Neuronal Signal | 2021 | 34956651 | PubTator, text mining | PubMed |
| Autism-Related Transcription Factors Underlying the Sex-Specific Effects of Prenatal Bisphenol A Exposure on Transcriptome-Interactome Profiles in the Offspring Prefrontal Cortex. | Int J Mol Sci | 2021 | 34947998 | PubTator, text mining | PubMed |
| Single Cell Sequencing of Induced Pluripotent Stem Cell Derived Retinal Ganglion Cells (iPSC-RGC) Reveals Distinct Molecular Signatures and RGC Subtypes. | Genes (Basel) | 2021 | 34946963 | PubTator, text mining | PubMed |
| Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages. | Biomedicines | 2021 | 34944628 | PubTator, text mining | PubMed |
Inhibition of β-catenin dependent WNT signalling upregulates the transcriptional repressor NR0B1 and downregulates markers of an A9 phenotype in human embryonic stem cell-derived dopaminergic neurons: Implications for Parkinson's disease. | PLoS One | 2021 | 34941945 | PubTator, text mining | PubMed |
| Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids. | Membranes (Basel) | 2021 | 34940418 | PubTator, text mining | PubMed |
| Development and Validation of a Robust Ferroptosis-Related Gene Panel for Breast Cancer Disease-Specific Survival. | Front Cell Dev Biol | 2021 | 34900981 | PubTator, text mining | PubMed |
| Microenvironmental Variations After Blood-Brain Barrier Breakdown in Traumatic Brain Injury. | Front Mol Neurosci | 2021 | 34899180 | PubTator, text mining | PubMed |
| Microenvironmental Factors Modulating Tumor Lipid Metabolism: Paving the Way to Better Antitumoral Therapy. | Front Oncol | 2021 | 34888248 | PubTator, text mining | PubMed |
| Cell-of-Origin and Genetic, Epigenetic, and Microenvironmental Factors Contribute to the Intra-Tumoral Heterogeneity of Pediatric Intracranial Ependymoma. | Cancers (Basel) | 2021 | 34885210 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2173/papers?page=24